-
No prescription for online prescription?
Time of Update: 2021-06-01
Some prescription drugs need to be selected according to the patient's physiological state, or some special inspections are required before and after the medication, such as antihypertensive drugs and the drugs for the treatment of hypothyroidism purchased by the Beijing Youth Daily reporter during the investigation.
-
Innovative topical drug for the treatment of presbyopia reaches phase 3 clinical endpoint
Time of Update: 2021-06-01
Note: The original text has been deletedReference materials:[1] Eyenovia Announces Positive Topline Results from VISION-1 Phase 3 Clinical Study of MicroLine for the Treatment of Presbyopia.
Retrieved May 25, 2021, from /2235613/0/en/Eyenovia-Announces-Positive-Topline-Results-from-VISION-1-Phase-3-Clinical-Study-of-MicroLine-for-the-Treatment-of-Presbyopia.
-
New medicine for T cell lymphoma!
Time of Update: 2021-06-01
Japanese pharmaceutical company Eisai (Eisai) recently announced that it has launched an anticancer drug Remitoro 300μg (denileukin diftitox [gene recombination]) intravenously in Japan, the drug is used to treat: relapsed or refractory peripheral T-cell lymphoma (PTCL) , Relapsed or refractory cutaneous T-cell lymphoma (CTCL).
-
GlaxoSmithKline/Vir neutralizing antibody sotrovimab was granted emergency use authorization by the U.S. FDA
Time of Update: 2021-06-01
CompilenewbornOn May 26, the US FDA granted emergency use authorization (EUA) for the COVID-19 monoclonal antibody drug sotrovimab for mild to moderate patients who tested positive for the virus and have a high risk of developing severe COVID-19 (including hospitalization and death) Adults and adolescents (12 years and older, weighing at least 40 kg) patients.
-
Betta Pharmaceuticals applies for new indications of icotinib to enter the "under review"
Time of Update: 2021-06-01
According to the acceptance number and the prior priority review and publicity information, the new indications that are expected to be approved this time are: single-drug use for postoperative adjuvant treatment of stage II-IIIA non-small cell lung cancer (NSCLC) with sensitive mutations in the EGFR gene.
-
Science: Reveals four worrying mechanisms for evading immune response of new coronavirus variants
Time of Update: 2021-06-01
They used structural biology techniques to describe how important neutralizing antibody classes bind to the original epidemic strain of SARS-CoV-2, and how this binding process was first discovered in Brazil, the United Kingdom, South Africa, and India.
-
The secondary hyperparathyroidism drug etacatide is reported to be produced in China
Time of Update: 2021-06-01
Cinacalcet is the first oral calcium-sensitive receptor agonist approved by the FDA for the treatment of SHPT in adult CKD patients undergoing dialysis treatment.
-
Bayer's 4 billion anti-thrombotic drugs are in a hurry!
Time of Update: 2021-06-01
On May 24, the official website of the State Food and Drug Administration showed that five companies including Qilu Pharmaceutical, Dongguan Yangzhikang Pharmaceutical, and Hunan Jiudian Pharmaceutical were approved for listing on the same day as Rivaroxaban tablets.
-
Ceftriaxone Sodium for Injection, a subsidiary of Shanghai Modern Pharmaceutical, passed the consistency evaluation of generic drugs
Time of Update: 2021-06-01
In 2020, the sales revenue of Sinopharm Zhijun Ceftriaxone Sodium for Injection (1.
Up to now, Sinopharm Zhijun has invested approximately RMB 10 million in research and development (unaudited) in the development of the consistency evaluation of ceftriaxone sodium for injection (1.
-
Dongyangguang: Aripiprazole orally disintegrating tablets obtained drug registration certificate
Time of Update: 2021-06-01
Aripiprazole is used to treat schizophrenia and belongs to the second generation of antipsychotic drugs.
The product is aripiprazole orally disintegrating tablets, which is one of 27 generic drugs purchased by the company's holding subsidiary, Yichang Dongyang Yangtze Yangtze Pharmaceutical Co.
-
CSPC Class 1 New Drugs Outbreak, 8 New Drugs Approved for Clinical Practice
Time of Update: 2021-06-01
Medical Network, May 27 News On May 25, CSPC issued an announcement stating that the new class 1 drug SYHX1903 was approved for clinical trials in China.
Since 2021, CSPC has been approved as a domestic clinical Class 1 new drug Data source: Mi Nei. com database, company announcement
-
Scientists find that high-salt diet can induce inflammatory diseases
Time of Update: 2021-06-01
Recently, a research team from the Max Delbrück Center for Molecular Medicine of the Helmholtz Federation in Germany found that a high-salt diet inhibits the activity of human mononuclear phagocyte mitochondria, thereby affecting the normal functioning of the immune system.
-
AstraZeneca's new crown vaccine Vaxzevria approved in Japan for people 18 years and older
Time of Update: 2021-06-01
Recently, AstraZeneca announced that its COVID-19 vaccine Vaxzevria (ChAdOx1-S [recombinant], formerly known as AZD1222) has been approved for emergency use in Japan for active immunization of people aged 18 and over.
-
Zvezumab inhibits IL-6 and significantly reduces the risk of atherosclerosis in high-risk patients
Time of Update: 2021-06-01
Adverse reactionsIn short, studies have shown that Zevezumab can significantly reduce inflammation and thrombosis associated with atherosclerosis.
Let us hope that the drug can benefit the majority of patients with atherosclerosis.
-
up to date!
Time of Update: 2021-06-01
On May 26, the State Food and Drug Administration issued an announcement on protected varieties of traditional Chinese medicines.
will continue to be given 2 Level of protection, the protection period and the number of protected varieties are respectively May 06, 2021-May 9, 2027, ZYB20720200101.
-
Shiver, pharmaceutical manufacturers!
Time of Update: 2021-06-01
Does your company's laboratory test results meet the requirements of relevant standards?
Does your company's laboratory test results meet the requirements of relevant standards?In addition, OOS/OOE/OOT management.
-
Smoking during pregnancy may increase children's risk of congenital heart disease
Time of Update: 2021-06-01
A study released on the 27th by the University of Bristol in the United Kingdom stated that women smoking during pregnancy may increase the risk of congenital heart disease in their children.
-
Improving the level of medical service The Chinese Clinical Practice Guidelines Alliance is here
Time of Update: 2021-06-01
Han Qide, academician of the Chinese Academy of Sciences, believes that since the 21st century, my country has gone through a arduous journey from simply introducing and interpreting international guidelines to gradually revising and compiling clinical diagnosis and treatment guidelines for different disciplines, and the level of medical services has been continuously improved.
-
Scientists find that mitochondrial enzymes can prevent iron death
Time of Update: 2021-06-01
Recently, a research team at the University of Texas Anderson Cancer Center discovered that the mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) plays an important role in inhibiting iron death (ferroptosis).
-
Sialon Pharmaceuticals: The company's omeprazole sodium for injection passed the consistency evaluation of generic drugs
Time of Update: 2021-06-01
The main indication for omeprazole sodium for injection that passed the generic drug consistency evaluation this time is for the treatment of acute upper gastrointestinal bleeding caused by duodenal ulcer, gastric ulcer, acute gastric mucosal lesions, and compound ulcers.
